In this high-impact, field-based role, you will drive the adoption and growth of Signatera , Natera's personalized molecular residual disease (MRD) ctDNA assay, helping clinicians monitor cancer and inform treatment decisions throughout the patient journey. You will collaborate cross-functionally to expand access to Signatera while partnering with Radiation Oncologists, ENT/Otolaryngology physicians, Head & Neck Surgeons, Medical Oncologists, Pathologists, and other members of the multidisciplinary care team.